Wessel N. van Wieringen

Wessel N. van Wieringen

Auto-generated profile, based on publicly available information

Wessel N. van Wieringen

Methodology, Amsterdam Public Health, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
CBClaire Bridel
Claire Bridel
WWWessel N. van Wieringen
Wessel N. van Wieringen
HZHenrik Zetterberg
Henrik Zetterberg
BTBetty M. Tijms
Betty M. Tijms
CTCharlotte E. Teunissen
Charlotte E. Teunissen
EWEdward Wild
Edward Wild
Identifying neuroaxonal damage and quantifying the intensity of this process is a critical step in patient care because it may support diagnosis and help estimate the prognosis of neurological conditions. In addition, it is essential for the evaluation of drug candidates with disease-modifying potential. Neurofilament light protein (NfL) is an abundant cytoskeletal protein exclusively expressed by central and peripheral neurons. Elevated levels of NfL in cerebrospinal fluid (CSF) were first reported in neurodegenerative conditions more than 20 years ago,1 sparking interest in the potential of this neuron-specific protein as a biomarker. Since then, elevated levels of NfL in CSF (cNfL) have been described in a number of neurological and psychiatric conditions. The magnitude of the increase in inflammatory, degenerative, infectious, ischemic, and traumatic neurological conditions, as well as in psychiatric disorders, varies between conditions and studies. To date, cNfL levels have not been compared systematically between neurological disorders, and patient numbers in individual studies are often low. A positive association between cNfL and age has been reported in healthy controls (HC)2 but was not systematically investigated in neurological conditions and may alter the performance of this biomarker across age categories. Together, these questions limit clinical implementation of cNfL. To compare cNfL levels between diagnoses, assess the association of age and sex with these variables, and evaluate the potential of cNfL level as a diagnostic biomarker, we performed a systematic review and meta-analysis on individual data collected from studies reporting cNfL levels in diseases and controls.

27 September 2010 in Brain
Verified
Journal Article
Open access
PDF file
MSMarjan E. Steenweg
Marjan E. Steenweg
AVAdeline Vanderver
Adeline Vanderver
SBSusan Blaser
Susan Blaser
ABAlberto Bizzi
Alberto Bizzi
TKTom J. de Koning
Tom J. de Koning
MKMarjo S. van der Knaap
Marjo S. van der Knaap
Hypomyelination is observed in the context of a growing number of genetic disorders that share clinical characteristics. The aim of this study was to determine the possible role of magnetic resonance imaging pattern recognition in distinguishing different hypomyelinating disorders, which would facilitate the diagnostic process. Only patients with hypomyelination of known cause were included in this retrospective study. A total of 112 patients with Pelizaeus–Merzbacher disease, hypomyelination with congenital cataract, hypomyelination with hypogonadotropic hypogonadism and hypodontia, Pelizaeus–Merzbacher-like disease, infantile GM1 and GM2 gangliosidosis, Salla disease and fucosidosis were included. The brain scans were rated using a standard scoring list; the raters were blinded to the diagnoses. Grouping of the patients was based on cluster analysis. Ten clusters of patients with similar magnetic resonance imaging abnormalities were identified. The most important discriminating items were early cerebellar atrophy, homogeneity of the white matter signal on T2-weighted images, abnormal signal intensity of the basal ganglia, signal abnormalities in the pons and additional T2 lesions in the deep white matter. Eight clusters each represented mainly a single disorder (i.e. Pelizaeus–Merzbacher disease, hypomyelination with congenital cataract, hypomyelination with hypogonadotropic hypogonadism and hypodontia, infantile GM1 and GM2 gangliosidosis, Pelizaeus–Merzbacher-like disease and fucosidosis); only two clusters contained multiple diseases. Pelizaeus–Merzbacher-like disease was divided between two clusters and Salla disease did not cluster at all. This study shows that it is possible to separate patients with hypomyelination disorders of known cause in clusters based on magnetic resonance imaging abnormalities alone. In most cases of Pelizaeus–Merzbacher disease, hypomyelination with congenital cataract, hypomyelination with hypogonadotropic hypogonadism and hypodontia, Pelizaeus–Merzbacher-like disease, infantile GM1 and GM2 gangliosidosis and fucosidosis, the imaging pattern gives clues for the diagnosis.

31 January 2007 in Bioinformatics
Verified
Journal Article
Open access
PDF file
MWMark A. van de Wiel
Mark A. van de Wiel
KKKyung In Kim
Kyung In Kim
SVSjoerd J. Vosse
Sjoerd J. Vosse
WWWessel N. van Wieringen
Wessel N. van Wieringen
SWSaskia Wilting
Saskia Wilting
BYBauke Ylstra
Bauke Ylstra
Summary: CGHcall achieves high calling accuracy for array CGH data by effective use of breakpoint information from segmentation and by inclusion of several biological concepts that are ignored by existing algorithms. The algorithm is validated for simulated and verified real array CGH data. By incorporating more than three classes, CGHcall improves detection of single copy gains and amplifications. Moreover, it allows effective inclusion of chromosome arm information. Availability: An R-package (GUI), a manual and an example data set are available at http://www.few.vu.nl/~mavdwiel/CGHcall.html. Contact:mark.vdwiel@vumc.nl Supplementary information: Supplementary data are available at Bioinformatics online.

13 September 2015 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
MWMark A. van de Wiel
Mark A. van de Wiel
TLTonje G. Lien
Tonje G. Lien
WVWina Verlaat
Wina Verlaat
WWWessel N. van Wieringen
Wessel N. van Wieringen
SWSaskia Wilting
Saskia Wilting

17 September 2012 in Biostatistics
Verified
Journal Article
Open access
PDF file
MWMark A. Van De Wiel
Mark A. Van De Wiel
GLGwenaël G.R. Leday
Gwenaël G.R. Leday
LPLuba Pardo
Luba Pardo
HRHåvard Rue
Håvard Rue
AVAad W. Van Der Vaart
Aad W. Van Der Vaart
WWWessel N. Van Wieringen
Wessel N. Van Wieringen
Next generation sequencing is quickly replacing microarrays as a technique to probe different molecular levels of the cell, such as DNA or RNA. The technology provides higher resolution, while reducing bias. RNA sequencing results in counts of RNA strands. This type of data imposes new statistical challenges. We present a novel, generic approach to model and analyze such data. Our approach aims at large flexibility of the likelihood (count) model and the regression model alike. Hence, a variety of count models is supported, such as the popular NB model, which accounts for overdispersion. In addition, complex, non-balanced designs and random effects are accommodated. Like some other methods, our method provides shrinkage of dispersion-related parameters. However, we extend it by enabling joint shrinkage of parameters, including those for which inference is desired. We argue that this is essential for Bayesian multiplicity correction. Shrinkage is effectuated by empirically estimating priors. We discuss several parametric (mixture) and non-parametric priors and develop procedures to estimate (parameters of) those. Inference is provided by means of local and Bayesian false discovery rates. We illustrate our method on several simulations and two data sets, also to compare it with other methods. Model- and data-based simulations show substantial improvements in the sensitivity at the given specificity. The data motivate the use of the ZI-NB as a powerful alternative to the NB, which results in higher detection rates for low-count data. Finally, compared with other methods, the results on small sample subsets are more reproducible when validated on their large sample complements, illustrating the importance of the type of shrinkage.

1 March 2009 in Computational Statistics & Data Analysis
Verified
Journal Article
Closed access
WWWessel N. van Wieringen
Wessel N. van Wieringen
DKDavid Kun
David Kun
RHRegina Hampel
Regina Hampel
ABAnne-Laure Boulesteix
Anne-Laure Boulesteix